DNM2 and centronuclear myopathy: Based on the hypothesis that these genes are in the same cellular pathway of membrane remodeling and that DNM2 gain-of-function is a common pathomechanism for several CNM forms, downregulation of DNM2 was proposed as a therapeutic strategy.